| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 03/22/2005 | US6870052 Preparation of thioarabinofuranosyl compounds and use thereof |
| 03/22/2005 | US6870048 Process for the preparation of 2'-halo-β-L-arabinofuranosyl nucleosides |
| 03/22/2005 | US6869764 Nucleic acid sequencing using charge-switch nucleotides |
| 03/17/2005 | WO2005023829A1 Metal complex type nucleic acid |
| 03/17/2005 | WO2005023827A1 Process for preparing antiviral nucleoside derivatives |
| 03/17/2005 | WO2005023826A2 Polymorphic nucleoside compounds |
| 03/17/2005 | US20050059817 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives |
| 03/17/2005 | US20050059815 Processes for the synthesis of 2'-O-substituted pyrimidines and oligomeric compounds therefrom |
| 03/17/2005 | US20050059632 Synthesis of beta-L-2'-deoxy nucleosides |
| 03/17/2005 | US20050059619 Immunostimulatory nucleic acids |
| 03/17/2005 | US20050059037 Undergoing a change in the fluorescent signal intensity depending on the corresponding base type in the partner strand with which the single-stranded sequence is hybridized |
| 03/17/2005 | CA2537878A1 Polymorphic nucleoside compounds |
| 03/17/2005 | CA2537849A1 Process for preparing antiviral nucleoside derivatives |
| 03/16/2005 | EP1513858A2 Process for the preparation of heterocyclyl substituted adenosine derivatives |
| 03/16/2005 | EP1513402A1 Improved inhibitors of adp-ribosyl transferases, cyclases, and hydrolases |
| 03/16/2005 | EP0716604B1 Thiol-derivatized nucleosides and oligonucleosides |
| 03/16/2005 | CN1596263A Aryl fused azapolycyclic compounds |
| 03/16/2005 | CN1596111A Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 03/16/2005 | CN1594342A Glycosyl phthalic imidine compounds with anti-inflammatory activity |
| 03/16/2005 | CN1593764A Catalyst for preparing isoamyl acetate and preparation method thereof |
| 03/15/2005 | US6867294 Design and synthesis of nuclease resistant gapped oligonucleotides which are useful for therapeutics, diagnostics and as research reagents ; are also capable of modulating the activity of DNA and RNA |
| 03/15/2005 | US6867199 Clearing retained mucous secretions, balancing tissue hydration and fluid secretion, and/or inhibiting or preventing early stages of platelet activation, degranulation and aggregation |
| 03/10/2005 | WO2005021778A2 Method and materials for polyamine catalyzed bisulfite conversion of cytosine to uracil |
| 03/10/2005 | WO2005021571A1 Method for producing n4-benzoylcytidine derivative |
| 03/10/2005 | WO2005021570A1 Novel artificial nucleic acids of n-o bond crosslinkage type |
| 03/10/2005 | WO2005021569A1 Avermectins and avermectin monosaccharides substituted in the 4’- and 4” position having pesticidal properties |
| 03/10/2005 | WO2005021568A2 Novel tricyclic nucleosides or nucleotides as therapeutic agents |
| 03/10/2005 | WO2005020885A2 Compositions and methods for the treatment of severe acute respiratory syndrome (sars) |
| 03/10/2005 | WO2005020884A2 Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses |
| 03/10/2005 | US20050054605 Partial or full A1 agonists - N6 heterocyclic 5' thio substituted adenosine derivatives |
| 03/10/2005 | US20050053972 Method for identifying polymorphisms |
| 03/10/2005 | US20050053945 Nucleosides; bioconjugation; solid phase synthesis |
| 03/10/2005 | US20050053928 Arrays for detecting nucleic acids |
| 03/09/2005 | EP1512691A1 Protecting groups for two-step polynucleotide synthesis |
| 03/09/2005 | EP1511757A1 New compounds for modulating the activity of exchange proteins directly activated by camp (epacs) |
| 03/09/2005 | CN1589908A Tenascin-C nucleic acid ligands |
| 03/09/2005 | CN1192102C Enzyme catalyzed therapeutic agents |
| 03/08/2005 | US6864366 By using halogen-free solvents in the first step of bromination of 5-ethlyl-2'- deoxyuridine diacylate |
| 03/08/2005 | US6864244 Polymorphism crystal structure; stability |
| 03/08/2005 | US6864243 Method for treating retinal degeneration with purinergic receptor agonists |
| 03/08/2005 | US6864059 Coupling a nucleic acid labeling compound (a biotin compound attached to a nucleic acid base derivative containing triphosphate) with a nucleic acid |
| 03/03/2005 | WO2005003147A3 Modified fluorinated nucleoside analogues |
| 03/03/2005 | WO2004065398A3 Synthesis and use of 2'-substituted-n6-modified nucleosides |
| 03/03/2005 | WO2002074911A3 Identification of gene expression alterations underlying the aging process in mammals |
| 03/03/2005 | US20050049411 Exocyclic amine triaryl methyl protecting groups in two step polynucleotide synthesis |
| 03/03/2005 | US20050049408 That retains the high RNA binding affinity of the parent oligonucleotide N3' --> P5' phosphoramidates and exhibits a much higher acid stability; inhibiting human telomerase enzyme activity; solid phase synthesis; kits |
| 03/03/2005 | US20050049407 Sugar with heterocyclic base having exocyclic amine group and substituted or unsubstituted triaryl methyl protecting group bound to exocyclic amine group |
| 03/03/2005 | US20050048519 Fluidic apparatus comprising biopolymer array for us ein detection of microorganisms in blood; genome diagnostic and metabolic disorders |
| 03/02/2005 | EP1510523A1 Precurors for two-step polynucleotide synthesis |
| 03/02/2005 | EP1509622A1 Fluorescence polarization detection of nucleic acids |
| 03/02/2005 | EP1183091A4 Optimization of ligand affinity for rna targets using mass spectrometry |
| 03/02/2005 | EP1151130B1 Coenzyme useful for the synthesis of l-carnitine |
| 03/02/2005 | CN1589144A Use of an ascomycin for the treatment of blepharitis |
| 03/02/2005 | CN1191266C Compositions for treating inflammatory response |
| 03/02/2005 | CN1191265C Process for preparation of trifluorothymidine derivatives |
| 03/02/2005 | CN1191264C Uridine derivatives as antibiotics |
| 03/01/2005 | US6861518 Hybrid oligonucleotide |
| 02/24/2005 | WO2005016514A2 Combinatorial synthesis on support |
| 02/24/2005 | WO2004009020A3 Pyrrolopyrimidine thionucleoside analogs as antivirals |
| 02/24/2005 | US20050043507 Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis |
| 02/24/2005 | US20050043394 For prophylaxis and therapy of diabetes mellitus, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases, neuropathic diseases, neuropathic pain and polyneuropathy; free fatty acids and/or fatty acid esters and uridine, deoxyuridine, uridine monophosphate, deoxyuridine monophosphate |
| 02/24/2005 | US20050043328 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation |
| 02/24/2005 | US20050043286 Use of an ascomycin for the treatment of blepharitis |
| 02/24/2005 | US20050043269 Pharmaceutically active uridine esters |
| 02/24/2005 | US20050043268 Inhibition of viruses |
| 02/24/2005 | US20050043265 High affinity RNA ligands of basic fibroblast growth factor |
| 02/24/2005 | CA2530604A1 Combinatorial synthesis on support |
| 02/23/2005 | EP0880598A4 Nucleic acid analysis techniques |
| 02/23/2005 | CN1583776A Preparing method for cytarabine |
| 02/23/2005 | CN1583771A Synthesis of carboxamido substituted nitrogen contained pentaheteronucleoside platinum complex |
| 02/23/2005 | CN1190198C Modulation of TH1/TH2 cytokine expression by Ribavirin and Ribavirin analogs activated T-lymphocytes |
| 02/22/2005 | US6858722 Oligomer phosphoramidite compositions and processes for synthesizing the same |
| 02/22/2005 | US6858711 Labeling reagents |
| 02/22/2005 | US6858624 Comprises 5,8,14-triazatetracyclo(10.3.1.0.0)-hexadeca-2(11),3,5,7,9-penaene groups; for reducing drug addiction, treating Alzheimer's/Parkinson's diseases, and other nervous system disorders |
| 02/22/2005 | US6858591 2-amino-3-hydroxy-3-uridyl-propanoic acid ester derivatives |
| 02/22/2005 | US6858582 Composition containing porous microparticle impregnated with biologically-active compound for treatment of infection |
| 02/22/2005 | US6858393 Chain terminators for DNA synthesis |
| 02/22/2005 | CA2257227C Substituted propargylethoxyamido nucleosides |
| 02/17/2005 | WO2005014610A1 Nucleoside capable of releasing functional unit through oxidation and process for producing oligonucleotide containing the same |
| 02/17/2005 | WO2005014609A2 Method of producing a highly stereoregular phosphorus atom-modified nucleotide analogue |
| 02/17/2005 | WO2004099131A3 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna |
| 02/17/2005 | WO2004016805A3 Immunostimulatory nucleic acids |
| 02/17/2005 | WO2004002999A8 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 02/17/2005 | WO2003106475A8 Process for the preparation of heterocyclyl substituted adenosine derivatives |
| 02/17/2005 | US20050038240 Processes for preparing 4'-azido-nucleoside derivatives |
| 02/17/2005 | US20050038025 Thioarabinofuranosyl compounds and use thereof |
| 02/17/2005 | US20050037991 Synthesis and compositions of 2'-terminator nucleotides |
| 02/17/2005 | US20050037470 Method of preparing a guanosine-group compound and an intermediate thereof |
| 02/17/2005 | US20050037396 compounds for analyzing primer extension products incorporating universal bases; microsatellite analysis |
| 02/16/2005 | EP1419167B1 1-(2,5'-anhydro-lyxofuranosyl) thymines for the synthesis of radiomarked fluoro-3' deoxynucleotides |
| 02/16/2005 | CN1580066A Method for modifying nucleoside by spiro pyran and spiro oxazine photo chromic compound |
| 02/15/2005 | US6855818 Vasodilation; heart imaging |
| 02/15/2005 | US6855698 Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
| 02/15/2005 | US6855500 Fluorescence-based genotyping |
| 02/15/2005 | US6855496 Detection of preferential nucleic acid ligands; obtain nucleotide sequences, incubate with oligonucleotides, hybridize, amplify, recover nucleotide sequences |
| 02/10/2005 | WO2005012327A2 Nucleotide phosphoramidates as anticancer agents |
| 02/10/2005 | WO2005012326A1 Novel compounds having inhibitory activity against sodium-dependant transporter |
| 02/10/2005 | WO2005012325A1 Process for preparing 2',3'-didehydro-2',3'-dideoxynucleosides and 2',3'-dideoxynucleosides |
| 02/10/2005 | WO2005012323A2 Compounds useful as a3 adenosine receptor agonists |
| 02/10/2005 | WO2005011709A1 Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections |